Control of antimicrobial resistance: time for action. The essentials of control are already well known.
作者信息
Huovinen P, Cars O
出版信息
BMJ. 1998 Sep 5;317(7159):613-4. doi: 10.1136/bmj.317.7159.613.
Abstract
摘要
相似文献
1
Control of antimicrobial resistance: time for action. The essentials of control are already well known.控制抗菌药物耐药性：行动时刻已至。控制的要点早已为人所知。
BMJ. 1998 Sep 5;317(7159):613-4. doi: 10.1136/bmj.317.7159.613.
2
3
[Antibiotic pressure and bacterial resistance in the hospital].[医院中的抗生素压力与细菌耐药性]
Presse Med. 1998 Jun;27 Suppl 3:5-14.
4
Containment of antibiotic resistance.抗生素耐药性的遏制
Science. 1998 Feb 20;279(5354):1153-4. doi: 10.1126/science.279.5354.1153.
5
[Antibiotic strategies: good practices in intensive care].[抗生素策略：重症监护中的良好实践]
Presse Med. 2000 Feb 5;29(4):225-7.
6
7
Controlling antimicrobial resistance. An integrated action plan for Canadians.控制抗菌药物耐药性。加拿大人综合行动计划。
Can Commun Dis Rep. 1997 Nov;23 Suppl 7:i-iv, 1-32, i-iv, 1-32.
8
[Standardization of antimicrobial procedures using computers].[使用计算机对抗菌程序进行标准化]
Rev Hosp Clin Fac Med Sao Paulo. 1985 Sep-Oct;40(5):227-32.
9
10
Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.监测医院微生物中的抗菌药物耐药性。问题的定义与方法
Dan Med Bull. 1990 Jun;37(3):263-74.
引用本文的文献
1
Approach to the Control of Antimicrobial Resistance: Are We Missing the Plot?抗菌药物耐药性控制方法：我们是否忽略了关键所在？
Indian J Crit Care Med. 2020 Oct;24(10):899-900. doi: 10.5005/jp-journals-10071-23626.
2
A review of complications of odontogenic infections.牙源性感染并发症综述。
Natl J Maxillofac Surg. 2015 Jul-Dec;6(2):136-43. doi: 10.4103/0975-5950.183867.
3
Update on the clinical utility and optimal use of cefditoren.头孢地尼的临床实用性和最佳使用方法的最新进展。
Int J Gen Med. 2012;5:455-64. doi: 10.2147/IJGM.S25989. Epub 2012 May 21.
4
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.社区获得性呼吸道感染中的耐药性：新兴抗菌药物的作用。
Infect Drug Resist. 2010;3:35-43. doi: 10.2147/idr.s8964. Epub 2010 Jun 18.
5
Cefditoren in upper and lower community-acquired respiratory tract infections.头孢地尼用于上下呼吸道社区获得性感染
Drug Des Devel Ther. 2011 Feb 9;5:85-94. doi: 10.2147/DDDT.S9499.
6
Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.引起医源性尿路感染的革兰氏阴性杆菌中氟喹诺酮类耐药的危险因素。
J Hosp Infect. 2010 Dec;76(4):324-7. doi: 10.1016/j.jhin.2010.05.023.
7
C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis.在全科医疗中进行C反应蛋白检测可能会减少鼻窦炎的抗生素处方。
Br J Gen Pract. 2004 Sep;54(506):659-62.
8
Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing.全科医疗中治疗咳嗽的抗生素使用情况：一项旨在量化并归纳用药原因的问卷调查研究
BMC Fam Pract. 2002 Sep 9;3:16. doi: 10.1186/1471-2296-3-16.
9
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.1684株肺炎链球菌和2039株化脓性链球菌分离株的抗菌药敏性及其生态关系：西班牙一项为期1年（1998 - 1999年）的多中心监测研究结果
Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40. doi: 10.1128/AAC.45.12.3334-3340.2001.
10
Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study.英国全科医疗中的抗菌药物处方与抗菌药物耐药性：横断面研究
BMJ. 2001 Nov 3;323(7320):1037-41. doi: 10.1136/bmj.323.7320.1037.
本文引用的文献
1
Changes in reimbursement policy for antibiotics and prescribing patterns in general practice.抗生素报销政策的变化与全科医疗中的处方模式
Clin Microbiol Infect. 1997 Feb;3(6):653-657. doi: 10.1111/j.1469-0691.1997.tb00473.x.
2
Limiting the spread of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.限制耐青霉素肺炎链球菌的传播：瑞典南部肺炎球菌干预项目的经验
Microb Drug Resist. 1998 Summer;4(2):99-105. doi: 10.1089/mdr.1998.4.99.
3
Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study.患者期望对全科医疗中急性下呼吸道疾病抗生素管理的影响：问卷调查研究
BMJ. 1997 Nov 8;315(7117):1211-4. doi: 10.1136/bmj.315.7117.1211.
4
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients.预防抗菌药物耐药性的出现。临床医生、公共卫生官员及患者的行动呼吁。
JAMA. 1997 Sep 17;278(11):944-5. doi: 10.1001/jama.278.11.944.
5
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.芬兰大环内酯类抗生素消费变化对A组链球菌红霉素耐药性的影响。芬兰抗菌药物耐药性研究小组。
N Engl J Med. 1997 Aug 14;337(7):441-6. doi: 10.1056/NEJM199708143370701.
6
Antimicrobials for acute otitis media? A review from the International Primary Care Network.用于治疗急性中耳炎的抗菌药物？来自国际初级保健网络的综述。
BMJ. 1997 Jul 12;315(7100):98-102. doi: 10.1136/bmj.315.7100.98.
7
Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci.
Microb Drug Resist. 1997 Summer;3(2):117-23. doi: 10.1089/mdr.1997.3.117.
8
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.美国医疗保健流行病学学会和美国传染病学会抗菌药物耐药性预防联合委员会：医院抗菌药物耐药性预防指南。
Infect Control Hosp Epidemiol. 1997 Apr;18(4):275-91. doi: 10.1086/647610.
9
Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units.替代洗手剂在降低重症监护病房医院感染方面的比较疗效
N Engl J Med. 1992 Jul 9;327(2):88-93. doi: 10.1056/NEJM199207093270205.
Zotero 插件